InteractionID         	REL_ENT  	REG_DIR 	INDIRECT 	PASSIVE 	NEGATED 	SENTENCE
miRNA-corp.d1.s0.p2   	MIR_GENE 	DOWN    	TRUE    	FALSE   	TRUE   	Our data suggests that down-regulation of <e1>miRNA-128</e1> may contribute to glioma and GBM, in part, by coordinately up-regulating <e2>ARP5</e2> (ANGPTL6), Bmi-1 and E2F-3a, resulting in the proliferation of undifferentiated GBM cells.
miRNA-corp.d1.s0.p3   	MIR_GENE 	DOWN    	TRUE    	FALSE   	TRUE   	Our data suggests that down-regulation of <e1>miRNA-128</e1> may contribute to glioma and GBM, in part, by coordinately up-regulating ARP5 (<e2>ANGPTL6</e2>), Bmi-1 and E2F-3a, resulting in the proliferation of undifferentiated GBM cells.
miRNA-corp.d1.s0.p4   	MIR_GENE 	DOWN    	TRUE    	FALSE   	TRUE   	Our data suggests that down-regulation of <e1>miRNA-128</e1> may contribute to glioma and GBM, in part, by coordinately up-regulating ARP5 (ANGPTL6), <e2>Bmi-1</e2> and E2F-3a, resulting in the proliferation of undifferentiated GBM cells.
miRNA-corp.d1.s1.p0   	MIR_GENE 	NEU    	FALSE    	FALSE   	FALSE   	Addition of exogenous <e1>miRNA-128</e1> to CRL-1690 and CRL-2610 GBM cell lines (a) restored 'homeostatic' <e2>ARP5</e2> (ANGPTL6), Bmi-1 and E2F-3a expression, and (b) significantly decreased the proliferation of CRL-1690 and CRL-2610 cell lines.
miRNA-corp.d1.s1.p1   	MIR_GENE 	NEU    	FALSE    	FALSE   	FALSE   	Addition of exogenous <e1>miRNA-128</e1> to CRL-1690 and CRL-2610 GBM cell lines (a) restored 'homeostatic' ARP5 (<e2>ANGPTL6</e2>), Bmi-1 and E2F-3a expression, and (b) significantly decreased the proliferation of CRL-1690 and CRL-2610 cell lines.
miRNA-corp.d1.s1.p2   	MIR_GENE 	NEU    	FALSE    	FALSE   	FALSE   	Addition of exogenous <e1>miRNA-128</e1> to CRL-1690 and CRL-2610 GBM cell lines (a) restored 'homeostatic' ARP5 (ANGPTL6), <e2>Bmi-1</e2> and E2F-3a expression, and (b) significantly decreased the proliferation of CRL-1690 and CRL-2610 cell lines.
miRNA-corp.d1.s2.p0   	MIR_GENE 	TARGET    	FALSE    	FALSE   	FALSE   	Three bioinformatics-verified <e1>miRNA-128</e1> targets, <e2>angiopoietin-related growth factor protein 5</e2> (ARP5; ANGPTL6), a transcription suppressor that promotes stem cell renewal and inhibits the expression of known tumor suppressor genes involved in senescence and differentiation, Bmi-1, and a transcription factor critical for the control of cell-cycle progression, E2F-3a, were found to be up-regulated.
miRNA-corp.d1.s2.p1   	MIR_GENE 	TARGET    	FALSE    	FALSE   	FALSE   	Three bioinformatics-verified <e1>miRNA-128</e1> targets, angiopoietin-related growth factor protein 5 (<e2>ARP5</e2>; ANGPTL6), a transcription suppressor that promotes stem cell renewal and inhibits the expression of known tumor suppressor genes involved in senescence and differentiation, Bmi-1, and a transcription factor critical for the control of cell-cycle progression, E2F-3a, were found to be up-regulated.
miRNA-corp.d1.s2.p2   	MIR_GENE 	TARGET    	FALSE    	FALSE   	FALSE   	Three bioinformatics-verified <e1>miRNA-128</e1> targets, angiopoietin-related growth factor protein 5 (ARP5; <e2>ANGPTL6</e2>), a transcription suppressor that promotes stem cell renewal and inhibits the expression of known tumor suppressor genes involved in senescence and differentiation, Bmi-1, and a transcription factor critical for the control of cell-cycle progression, E2F-3a, were found to be up-regulated.
miRNA-corp.d1.s2.p3   	MIR_GENE 	TARGET    	FALSE    	FALSE   	FALSE   	Three bioinformatics-verified <e1>miRNA-128</e1> targets, angiopoietin-related growth factor protein 5 (ARP5; ANGPTL6), a transcription suppressor that promotes stem cell renewal and inhibits the expression of known tumor suppressor genes involved in senescence and differentiation, <e2>Bmi-1</e2>, and a transcription factor critical for the control of cell-cycle progression, E2F-3a, were found to be up-regulated.
miRNA-corp.d1.s5.p1   	MIR_GENE 	DOWN    	FALSE    	FALSE   	FALSE   	<e1>Micro-RNA-128</e1> (miRNA-128) down-regulation in glioblastoma targets <e2>ARP5</e2> (ANGPTL6), Bmi-1 and E2F-3a, key regulators of brain cell proliferation.
miRNA-corp.d1.s5.p2   	MIR_GENE 	DOWN    	FALSE    	FALSE   	FALSE   	<e1>Micro-RNA-128</e1> (miRNA-128) down-regulation in glioblastoma targets ARP5 (<e2>ANGPTL6</e2>), Bmi-1 and E2F-3a, key regulators of brain cell proliferation.
miRNA-corp.d1.s5.p3   	MIR_GENE 	DOWN    	FALSE    	FALSE   	FALSE   	<e1>Micro-RNA-128</e1> (miRNA-128) down-regulation in glioblastoma targets ARP5 (ANGPTL6), <e2>Bmi-1</e2> and E2F-3a, key regulators of brain cell proliferation.
miRNA-corp.d1.s5.p5   	MIR_GENE 	DOWN    	FALSE    	FALSE   	FALSE   	Micro-RNA-128 (<e1>miRNA-128</e1>) down-regulation in glioblastoma targets <e2>ARP5</e2> (ANGPTL6), Bmi-1 and E2F-3a, key regulators of brain cell proliferation.
miRNA-corp.d1.s5.p6   	MIR_GENE 	DOWN    	FALSE    	FALSE   	FALSE   	Micro-RNA-128 (<e1>miRNA-128</e1>) down-regulation in glioblastoma targets ARP5 (<e2>ANGPTL6</e2>), Bmi-1 and E2F-3a, key regulators of brain cell proliferation.
miRNA-corp.d1.s5.p7   	MIR_GENE 	DOWN    	FALSE    	FALSE   	FALSE   	Micro-RNA-128 (<e1>miRNA-128</e1>) down-regulation in glioblastoma targets ARP5 (ANGPTL6), <e2>Bmi-1</e2> and E2F-3a, key regulators of brain cell proliferation.
miRNA-corp.d6.s0.p0   	MIR_GENE 	DOWN    	TRUE    	FALSE   	FALSE   	Reduction of <e1>miR-21</e1> induces glioma cell apoptosis via activating <e2>caspase 9</e2> and 3.  Extensive data indicate that miR-21 plays a critical role in gliomagenesis, however, knowledge is limited on the mechanism of action of miR-21, including cell proliferation, apoptosis, and migration.
miRNA-corp.d6.s0.p2   	NA       	NA      	FALSE    	FALSE   	FALSE   	Reduction of miR-21 induces glioma cell apoptosis via activating <e2>caspase 9</e2> and 3.  Extensive data indicate that <e1>miR-21</e1> plays a critical role in gliomagenesis, however, knowledge is limited on the mechanism of action of miR-21, including cell proliferation, apoptosis, and migration.
miRNA-corp.d6.s0.p4   	NA       	NA      	FALSE    	FALSE   	FALSE   	Reduction of miR-21 induces glioma cell apoptosis via activating <e2>caspase 9</e2> and 3.  Extensive data indicate that miR-21 plays a critical role in gliomagenesis, however, knowledge is limited on the mechanism of action of <e1>miR-21</e1>, including cell proliferation, apoptosis, and migration.
miRNA-corp.d6.s1.p0   	MIR_GENE 	DOWN    	TRUE    	FALSE   	FALSE   	Moreover, reduction of <e1>miR-21</e1> activated <e2>caspase 9</e2> and 3, which may be mediated by modulating multiple potential target genes, such as TIMP3.
miRNA-corp.d6.s1.p1   	MIR_GENE 	DOWN    	TRUE    	FALSE   	FALSE   	Moreover, reduction of <e1>miR-21</e1> activated caspase 9 and 3, which may be mediated by modulating multiple potential target genes, such as <e2>TIMP3</e2>.
miRNA-corp.d9.s1.p0   	MIR_GENE 	DOWN    	TRUE    	FALSE   	FALSE   	The reduction of the affinity of <e1>miR-433</e1> to the 3' UTR would result in increased <e2>FGF20</e2> expression and upregulation of alpha-synuclein, which could in turn promote dopaminergic neurons degeneration.
miRNA-corp.d9.s1.p1   	MIR_GENE 	DOWN    	TRUE    	FALSE   	FALSE   	The reduction of the affinity of <e1>miR-433</e1> to the 3' UTR would result in increased FGF20 expression and upregulation of <e2>alpha-synuclein</e2>, which could in turn promote dopaminergic neurons degeneration.
miRNA-corp.d9.s2.p0   	NA       	NA      	FALSE    	FALSE   	FALSE   	<e2>FGF20</e2> rs12720208 SNP and <e1>microRNA-433</e1> variation.;  no association with Parkinson's disease in Spanish patients.  
miRNA-corp.d11.s1.p0  	NA       	NA      	FALSE    	FALSE   	FALSE   	Moreover, the levels of the <e2>apl-1</e2> transcription are modulated by the activity of <e1>let-7</e1> family microRNAs.
miRNA-corp.d11.s6.p0  	NA       	NA      	FALSE    	FALSE   	FALSE   	C. elegans <e2>apl-1</e2> shows significant genetic interactions with <e1>let-7</e1> family microRNAs and let-7-targeted heterochronic genes, hbl-1, lin-41 and lin-42.
miRNA-corp.d11.s6.p1  	NA       	NA      	FALSE    	FALSE   	FALSE   	C. elegans apl-1 shows significant genetic interactions with <e1>let-7</e1> family microRNAs and let-7-targeted heterochronic genes, <e2>hbl-1</e2>, lin-41 and lin-42.
miRNA-corp.d11.s6.p2  	NA       	NA      	FALSE    	FALSE   	FALSE   	C. elegans apl-1 shows significant genetic interactions with <e1>let-7</e1> family microRNAs and let-7-targeted heterochronic genes, hbl-1, <e2>lin-41</e2> and lin-42.
miRNA-corp.d11.s6.p6  	NA       	NA      	FALSE    	FALSE   	FALSE   	C. elegans <e2>apl-1</e2> shows significant genetic interactions with let-7 family microRNAs and <e1>let-7</e1>-targeted heterochronic genes, hbl-1, lin-41 and lin-42.
miRNA-corp.d11.s6.p7  	NA       	NA      	FALSE    	FALSE   	FALSE   	C. elegans apl-1 shows significant genetic interactions with let-7 family microRNAs and <e1>let-7</e1>-targeted heterochronic genes, <e2>hbl-1</e2>, lin-41 and lin-42.
miRNA-corp.d11.s6.p8  	NA       	NA      	FALSE    	FALSE   	FALSE   	C. elegans apl-1 shows significant genetic interactions with let-7 family microRNAs and <e1>let-7</e1>-targeted heterochronic genes, hbl-1, <e2>lin-41</e2> and lin-42.
miRNA-corp.d17.s3.p4  	GENE_MIR 	NEU     	FALSE    	FALSE   	FALSE   	We show that <e2>SRF</e2> and myocardin regulate a cardiovascular-specific microRNA (miRNA) cluster encoding <e1>miR-143</e1> and miR-145.
miRNA-corp.d17.s3.p5  	GENE_MIR 	NEU      	FALSE    	FALSE   	FALSE   	We show that SRF and <e2>myocardin</e2> regulate a cardiovascular-specific microRNA (miRNA) cluster encoding <e1>miR-143</e1> and miR-145.
miRNA-corp.d17.s3.p6  	GENE_MIR 	NEU      	FALSE    	FALSE   	FALSE   	We show that <e2>SRF</e2> and myocardin regulate a cardiovascular-specific microRNA (miRNA) cluster encoding miR-143 and <e1>miR-145</e1>.
miRNA-corp.d17.s3.p7  	GENE_MIR 	NEU      	FALSE    	FALSE   	FALSE   	We show that SRF and <e2>myocardin</e2> regulate a cardiovascular-specific microRNA (miRNA) cluster encoding miR-143 and <e1>miR-145</e1>.
miRNA-corp.d17.s7.p0  	MIR_GENE 	NEU      	TRUE    	FALSE   	FALSE   	These abnormalities reflect the regulation of a cadre of modulators of <e2>SRF</e2> activity and actin dynamics by <e1>miR-143</e1> and miR-145.
miRNA-corp.d17.s7.p1  	MIR_GENE 	NEU      	TRUE    	FALSE   	FALSE   	These abnormalities reflect the regulation of a cadre of modulators of <e2>SRF</e2> activity and actin dynamics by miR-143 and <e1>miR-145</e1>.
miRNA-corp.d17.s8.p0  	NA       	NA      	FALSE    	FALSE   	FALSE   	Thus, <e1>miR-143</e1> and miR-145 act as integral components of the regulatory network whereby <e2>SRF</e2> controls cytoskeletal remodeling and phenotypic switching of SMCs during vascular disease.
miRNA-corp.d17.s8.p2  	NA       	NA      	FALSE    	FALSE   	FALSE   	Thus, miR-143 and <e1>miR-145</e1> act as integral components of the regulatory network whereby <e2>SRF</e2> controls cytoskeletal remodeling and phenotypic switching of SMCs during vascular disease.
miRNA-corp.d18.s0.p0  	NA       	NA      	FALSE    	FALSE   	FALSE   	This work represents the first experimental study showing that an <e1>miR-30</e1>-based shRNA construct prevents <e2>Oas1</e2> pathway associated off-target effects, which we consider as an essential prerequisite for shRNA use in future gene therapeutic approaches.
miRNA-corp.d18.s1.p0  	NA       	NA      	FALSE    	FALSE   	FALSE   	Modification of the shRNA construct by implementing features of the naturally occurring <e1>microRNA-30</e1> (miR-30) precursor avoided <e2>Oas1</e2> induction in transduced primary cultures, whereby modification of the passenger strand seems to be a crucial feature to circumvent interferon-stimulated gene expression.
miRNA-corp.d18.s1.p1  	NA       	NA      	FALSE    	FALSE   	FALSE   	Modification of the shRNA construct by implementing features of the naturally occurring microRNA-30 (<e1>miR-30</e1>) precursor avoided <e2>Oas1</e2> induction in transduced primary cultures, whereby modification of the passenger strand seems to be a crucial feature to circumvent interferon-stimulated gene expression.
miRNA-corp.d19.s1.p0  	MIR_GENE 	DOWN      	FALSE    	FALSE   	FALSE   	Downregulation of <e2>Pdcd4</e2> by <e1>mir-21</e1> facilitates glioblastoma proliferation in vivo.
miRNA-corp.d19.s4.p0  	MIR_GENE 	DOWN    	FALSE    	FALSE   	FALSE   	We demonstrate that downregulation of <e1>mir-21</e1> in glioblastoma-derived cell lines results in increased expression of its target, <e2>programmed cell death 4</e2> (Pdcd4), a known tumor-suppressor gene.
miRNA-corp.d19.s4.p1  	MIR_GENE 	DOWN    	FALSE    	FALSE   	FALSE   	We demonstrate that downregulation of <e1>mir-21</e1> in glioblastoma-derived cell lines results in increased expression of its target, programmed cell death 4 (<e2>Pdcd4</e2>), a known tumor-suppressor gene.
miRNA-corp.d19.s6.p2  	MIR_GENE 	DOWN    	FALSE    	FALSE   	FALSE   	Using a glioblastoma xenograft model in immune-deficient nude mice, we observe that glioblastoma-derived cell lines in which <e1>mir-21</e1> levels are downregulated or <e2>Pdcd4</e2> is over-expressed exhibit decreased tumor formation and growth.
miRNA-corp.d19.s7.p0  	MIR_GENE 	DOWN    	TRUE    	FALSE   	FALSE   	In addition, our data indicate that either downregulation of <e1>mir-21</e1> or overexpression of its target, <e2>Pdcd4</e2>, in glioblastoma-derived cell lines leads to decreased proliferation, increased apoptosis, and decreased colony formation in soft agar.
miRNA-corp.d19.s9.p0  	NA       	NA      	FALSE    	FALSE   	FALSE   	These critical in vivo findings demonstrate an important functional linkage between <e1>mir-21</e1> and <e2>Pdcd4</e2> and further elucidate the molecular mechanisms by which the known high level of mir-21 expression in glioblastoma can attribute to tumorigenesis--namely, inhibition of Pdcd4 and its tumor-suppressive functions.
miRNA-corp.d19.s9.p2  	NA       	NA      	FALSE    	FALSE   	FALSE   	These critical in vivo findings demonstrate an important functional linkage between <e1>mir-21</e1> and Pdcd4 and further elucidate the molecular mechanisms by which the known high level of mir-21 expression in glioblastoma can attribute to tumorigenesis--namely, inhibition of <e2>Pdcd4</e2> and its tumor-suppressive functions.
miRNA-corp.d19.s9.p3  	NA       	NA      	FALSE    	FALSE   	FALSE   	These critical in vivo findings demonstrate an important functional linkage between mir-21 and <e2>Pdcd4</e2> and further elucidate the molecular mechanisms by which the known high level of <e1>mir-21</e1> expression in glioblastoma can attribute to tumorigenesis--namely, inhibition of Pdcd4 and its tumor-suppressive functions.
miRNA-corp.d19.s9.p5  	MIR_GENE 	DOWN    	FALSE    	FALSE   	FALSE   	These critical in vivo findings demonstrate an important functional linkage between mir-21 and Pdcd4 and further elucidate the molecular mechanisms by which the known high level of <e1>mir-21</e1> expression in glioblastoma can attribute to tumorigenesis--namely, inhibition of <e2>Pdcd4</e2> and its tumor-suppressive functions.
miRNA-corp.d25.s6.p0  	MIR_GENE 	TARGET    	FALSE    	FALSE   	FALSE   	We have further identified that <e1>miR-145</e1>-mediated phenotypic modulation of VSMCs is through its target gene <e2>KLF5</e2> and its downstream signaling molecule, myocardin.
miRNA-corp.d25.s6.p1  	NA       	NA      	FALSE    	FALSE   	FALSE   	We have further identified that <e1>miR-145</e1>-mediated phenotypic modulation of VSMCs is through its target gene KLF5 and its downstream signaling molecule, <e2>myocardin</e2>.
miRNA-corp.d36.s7.p0  	MIR_GENE 	TARGET    	FALSE    	FALSE   	FALSE   	Endogenous <e1>miR-124a</e1> expression and the protein expression of three of its targets; IQ motif containing GTPase activating protein 1 (<e2>IQGAP1</e2>), laminin γ1 (LAMC1) and integrin β1 (ITGB1) were significantly reciprocally associated in the majority of the clinical cases.
miRNA-corp.d36.s7.p1  	MIR_GENE 	TARGET    	FALSE    	FALSE   	FALSE   	Endogenous <e1>miR-124a</e1> expression and the protein expression of three of its targets; <e2>IQ motif containing GTPase activating protein 1</e2> (IQGAP1), laminin γ1 (LAMC1) and integrin β1 (ITGB1) were significantly reciprocally associated in the majority of the clinical cases.
miRNA-corp.d36.s7.p2  	MIR_GENE 	TARGET    	FALSE    	FALSE   	FALSE   	Endogenous <e1>miR-124a</e1> expression and the protein expression of three of its targets; IQ motif containing GTPase activating protein 1 (IQGAP1), <e2>laminin γ1</e2> (LAMC1) and integrin β1 (ITGB1) were significantly reciprocally associated in the majority of the clinical cases.
miRNA-corp.d36.s7.p3  	MIR_GENE 	TARGET    	FALSE    	FALSE   	FALSE   	Endogenous <e1>miR-124a</e1> expression and the protein expression of three of its targets; IQ motif containing GTPase activating protein 1 (IQGAP1), laminin γ1 (<e2>LAMC1</e2>) and integrin β1 (ITGB1) were significantly reciprocally associated in the majority of the clinical cases.
miRNA-corp.d36.s7.p4  	MIR_GENE 	TARGET    	FALSE    	FALSE   	FALSE   	Endogenous <e1>miR-124a</e1> expression and the protein expression of three of its targets; IQ motif containing GTPase activating protein 1 (IQGAP1), laminin γ1 (LAMC1) and <e2>integrin β1</e2> (ITGB1) were significantly reciprocally associated in the majority of the clinical cases.
miRNA-corp.d36.s7.p5  	MIR_GENE 	TARGET    	FALSE    	FALSE   	FALSE   	Endogenous <e1>miR-124a</e1> expression and the protein expression of three of its targets; IQ motif containing GTPase activating protein 1 (IQGAP1), laminin γ1 (LAMC1) and integrin β1 (<e2>ITGB1</e2>) were significantly reciprocally associated in the majority of the clinical cases.
miRNA-corp.d40.s0.p3  	NA       	NA      	FALSE    	FALSE   	FALSE   	The clinical relevance of our findings was evaluated in HIV-encephalitis (HIVE) brain samples in which decreased levels of <e2>MCP-2</e2> and increased levels of <e1>mir-146a</e1> were observed, suggesting a role for mir-146a in the maintenance of HIV-mediated chronic inflammation of the brain.
miRNA-corp.d40.s0.p7  	NA       	NA      	FALSE    	FALSE   	FALSE   	The clinical relevance of our findings was evaluated in HIV-encephalitis (HIVE) brain samples in which decreased levels of <e2>MCP-2</e2> and increased levels of mir-146a were observed, suggesting a role for <e1>mir-146a</e1> in the maintenance of HIV-mediated chronic inflammation of the brain.
miRNA-corp.d40.s1.p0  	MIR_GENE 	TARGET      	TRUE    	FALSE   	FALSE   	We further show that <e2>CCL8</e2>/MCP-2 is a target for <e1>mir-146a</e1> in HIV-1 infected microglia, as overexpression of mir-146a prevented HIV-induced secretion of MCP-2 chemokine.
miRNA-corp.d40.s1.p1  	MIR_GENE 	TARGET      	TRUE    	FALSE   	FALSE   	We further show that CCL8/<e2>MCP-2</e2> is a target for <e1>mir-146a</e1> in HIV-1 infected microglia, as overexpression of mir-146a prevented HIV-induced secretion of MCP-2 chemokine.
miRNA-corp.d40.s1.p2  	NA       	NA      	FALSE    	FALSE   	FALSE   	We further show that CCL8/MCP-2 is a target for <e1>mir-146a</e1> in HIV-1 infected microglia, as overexpression of mir-146a prevented HIV-induced secretion of <e2>MCP-2 chemokine</e2>.
miRNA-corp.d40.s1.p3  	NA       	NA      	FALSE    	FALSE   	FALSE   	We further show that <e2>CCL8</e2>/MCP-2 is a target for mir-146a in HIV-1 infected microglia, as overexpression of <e1>mir-146a</e1> prevented HIV-induced secretion of MCP-2 chemokine.
miRNA-corp.d40.s1.p4  	NA       	NA      	FALSE    	FALSE   	FALSE   	We further show that CCL8/<e2>MCP-2</e2> is a target for mir-146a in HIV-1 infected microglia, as overexpression of <e1>mir-146a</e1> prevented HIV-induced secretion of MCP-2 chemokine.
miRNA-corp.d40.s1.p5  	MIR_GENE 	DOWN    	FALSE    	FALSE   	FALSE   	We further show that CCL8/MCP-2 is a target for mir-146a in HIV-1 infected microglia, as overexpression of <e1>mir-146a</e1> prevented HIV-induced secretion of <e2>MCP-2 chemokine</e2>.
miRNA-corp.d40.s4.p0  	MIR_GENE 	TARGET      	FALSE    	FALSE   	FALSE   	<e2>CCL8</e2>/MCP-2 is a target for <e1>mir-146a</e1> in HIV-1-infected human microglial cells.
miRNA-corp.d40.s4.p1  	MIR_GENE 	TARGET      	FALSE    	FALSE   	FALSE   	CCL8/<e2>MCP-2</e2> is a target for <e1>mir-146a</e1> in HIV-1-infected human microglial cells.
miRNA-corp.d40.s5.p0  	MIR_GENE 	TARGET    	FALSE    	FALSE   	FALSE   	Among the predicted gene targets for <e1>mir-146a</e1>, the <e2>chemokine CCL8</e2>/MCP-2 is a ligand for the CCR5 chemokine receptor and a potent inhibitor of CD4/CCR5-mediated HIV-1 entry and replication.
miRNA-corp.d40.s5.p1  	MIR_GENE 	TARGET    	FALSE    	FALSE   	FALSE   	Among the predicted gene targets for <e1>mir-146a</e1>, the chemokine CCL8/<e2>MCP-2</e2> is a ligand for the CCR5 chemokine receptor and a potent inhibitor of CD4/CCR5-mediated HIV-1 entry and replication.
miRNA-corp.d40.s5.p2  	MIR_GENE 	TARGET    	FALSE    	FALSE   	FALSE   	Among the predicted gene targets for <e1>mir-146a</e1>, the chemokine CCL8/MCP-2 is a ligand for the <e2>CCR5 chemokine receptor</e2> and a potent inhibitor of CD4/CCR5-mediated HIV-1 entry and replication.
miRNA-corp.d40.s5.p3  	MIR_GENE 	TARGET    	FALSE    	FALSE   	FALSE   	Among the predicted gene targets for <e1>mir-146a</e1>, the chemokine CCL8/MCP-2 is a ligand for the CCR5 chemokine receptor and a potent inhibitor of <e2>CD4</e2>/CCR5-mediated HIV-1 entry and replication.
miRNA-corp.d40.s5.p4  	MIR_GENE 	TARGET    	FALSE    	FALSE   	FALSE   	Among the predicted gene targets for <e1>mir-146a</e1>, the chemokine CCL8/MCP-2 is a ligand for the CCR5 chemokine receptor and a potent inhibitor of CD4/<e2>CCR5</e2>-mediated HIV-1 entry and replication.
miRNA-corp.d42.s3.p0  	MIR_GENE 	DOWN      	TRUE    	FALSE   	FALSE   	Downregulation of <e2>ABCG2</e2> expression in glioblastoma cancer stem cells with <e1>miRNA-328</e1> may decrease their chemoresistance.
miRNA-corp.d42.s4.p0  	MIR_GENE 	NEU      	FALSE    	FALSE   	FALSE   	Thus, we hypothesize that modulating <e2>ABCG2</e2> expression by targeting <e1>miRNA-328</e1> in glioblastoma cancer stem cells could represent a promising strategy for therapeutic manipulation to increase the efficacy of chemotherapeutic agents for glioblastoma, a highly lethal type of cancer.
miRNA-corp.d42.s6.p0  	MIR_GENE 	TARGET      	FALSE    	FALSE   	FALSE   	Some preliminary studies have shown that <e2>ABCG2</e2> is the target gene for <e1>miRNA-328</e1>.
miRNA-corp.d46.s1.p1  	MIR_GENE 	DOWN    	FALSE    	FALSE   	FALSE   	Foremost among these is <e1>miR-9</e1>, which suppresses mesenchymal differentiation in glioblastoma by downregulating expression of JAK kinases and inhibiting activation of <e2>STAT3</e2>.
miRNA-corp.d48.s0.p0  	MIR_GENE 	DOWN    	TRUE    	FALSE   	FALSE   	Co-suppression of <e1>miR-221/222</e1> directly resulted in the up-regulation of <e2>p27Kip1</e2> in the tested cells, consequently, affects their growth potential by reducing a G1 to S shift in the cell cycle.
miRNA-corp.d48.s1.p0  	MIR_GENE 	DOWN    	TRUE    	FALSE   	FALSE   	Consistently, <e1>miR-221/222</e1> knocked-down through antisense 2'-OME-oligonucleotides increased <e2>p27Kip1</e2> in U251 glioma subcutaneous mice and strongly reduced tumor growth in vivo through up regulation of p27Kip1.
miRNA-corp.d48.s1.p3  	MIR_GENE 	DOWN    	TRUE    	FALSE   	FALSE   	Consistently, <e1>miR-221/222</e1> knocked-down through antisense 2'-OME-oligonucleotides increased p27Kip1 in U251 glioma subcutaneous mice and strongly reduced tumor growth in vivo through up regulation of <e2>p27Kip1</e2>.
miRNA-corp.d48.s2.p0  	MIR_GENE 	TARGET    	FALSE    	FALSE   	FALSE   	Our results suggest that <e1>miR-221/222</e1> is a regulator of the tumor suppressor gene <e2>p27Kip1</e2>, and co-suppression of miR-221/222 expression in advanced gliomas may inhibit glioma cell proliferation by a mechanism involving the up-regulation of p27Kip1 in vitro and in vivo.
miRNA-corp.d48.s2.p3  	NA       	NA      	FALSE    	FALSE   	FALSE   	Our results suggest that <e1>miR-221/222</e1> is a regulator of the tumor suppressor gene p27Kip1, and co-suppression of miR-221/222 expression in advanced gliomas may inhibit glioma cell proliferation by a mechanism involving the up-regulation of <e2>p27Kip1</e2> in vitro and in vivo.
miRNA-corp.d48.s2.p4  	NA       	NA      	FALSE    	FALSE   	FALSE   	Our results suggest that miR-221/222 is a regulator of the tumor suppressor gene <e2>p27Kip1</e2>, and co-suppression of <e1>miR-221/222</e1> expression in advanced gliomas may inhibit glioma cell proliferation by a mechanism involving the up-regulation of p27Kip1 in vitro and in vivo.
miRNA-corp.d48.s2.p7  	MIR_GENE 	DOWN    	TRUE    	FALSE   	FALSE   	Our results suggest that miR-221/222 is a regulator of the tumor suppressor gene p27Kip1, and co-suppression of <e1>miR-221/222</e1> expression in advanced gliomas may inhibit glioma cell proliferation by a mechanism involving the up-regulation of <e2>p27Kip1</e2> in vitro and in vivo.
miRNA-corp.d48.s3.p1  	MIR_GENE 	TARGET    	TRUE    	FALSE   	FALSE   	Co-suppression of <e1>miR-221/222</e1> cluster suppresses human glioma cell growth by targeting <e2>p27kip1</e2> in vitro and in vivo.
miRNA-corp.d48.s6.p0  	NA       	NA      	FALSE    	FALSE   	FALSE   	In the current study, an inverse relationship between the expression of <e1>miR-221</e1>/miR-222 and the cell cycle inhibitor <e2>p27Kip1</e2> was identified in U251 glioma cells.
miRNA-corp.d48.s6.p2  	NA       	NA      	FALSE    	FALSE   	FALSE   	In the current study, an inverse relationship between the expression of miR-221/<e1>miR-222</e1> and the cell cycle inhibitor <e2>p27Kip1</e2> was identified in U251 glioma cells.
miRNA-corp.d51.s3.p0  	MIR_GENE 	NEU    	FALSE    	FALSE   	FALSE   	The data strongly suggested that a regulatory loop between <e1>miR-21</e1> and <e2>STAT3</e2> might provide an insight into the mechanism of modulating EGFR/STAT3 signaling.
miRNA-corp.d51.s3.p1  	NA       	NA      	FALSE    	FALSE   	FALSE   	The data strongly suggested that a regulatory loop between <e1>miR-21</e1> and STAT3 might provide an insight into the mechanism of modulating <e2>EGFR</e2>/STAT3 signaling.
miRNA-corp.d51.s3.p2  	NA       	NA      	FALSE    	FALSE   	FALSE   	The data strongly suggested that a regulatory loop between <e1>miR-21</e1> and STAT3 might provide an insight into the mechanism of modulating EGFR/<e2>STAT3</e2> signaling.
miRNA-corp.d53.s6.p0  	MIR_GENE 	DOWN    	FALSE    	FALSE   	FALSE   	<e1>miR-29b</e1> downregulates the expression of luciferase through hPGRN or mouse <e2>PGRN</e2> (mPGRN) 3'UTRs, and the regulation was abolished by mutations in the miR-29b binding site.
miRNA-corp.d53.s6.p1  	NA       	NA      	FALSE    	FALSE   	FALSE   	miR-29b downregulates the expression of luciferase through hPGRN or mouse <e2>PGRN</e2> (mPGRN) 3'UTRs, and the regulation was abolished by mutations in the <e1>miR-29b</e1> binding site.
miRNA-corp.d53.s7.p0  	MIR_GENE 	TARGET    	FALSE    	FALSE   	FALSE   	We identified an evolutionarily conserved binding site for <e1>microRNA-29b</e1> (miR-29b) in the 3' untranslated region (3'UTR) of the human <e2>PGRN</e2> (hPGRN) mRNA.
miRNA-corp.d53.s7.p1  	MIR_GENE 	TARGET    	FALSE    	FALSE   	FALSE   	We identified an evolutionarily conserved binding site for microRNA-29b (<e1>miR-29b</e1>) in the 3' untranslated region (3'UTR) of the human <e2>PGRN</e2> (hPGRN) mRNA.
miRNA-corp.d53.s8.p0  	MIR_GENE 	NEU    	FALSE    	FALSE   	FALSE   	<e1>MicroRNA-29b</e1> regulates the expression level of human <e2>progranulin</e2>, a secreted glycoprotein implicated in frontotemporal dementia.
miRNA-corp.d53.s9.p0  	MIR_GENE 	TARGET    	FALSE    	FALSE   	FALSE   	These findings identify <e1>miR-29b</e1> as a novel posttranscriptional regulator of <e2>PGRN</e2> expression, raising the possibility that miR-29b or other miRNAs might be targeted therapeutically to increase hPGRN levels in some FTD patients.
miRNA-corp.d53.s9.p2  	NA       	NA      	FALSE    	FALSE   	FALSE   	These findings identify miR-29b as a novel posttranscriptional regulator of <e2>PGRN</e2> expression, raising the possibility that <e1>miR-29b</e1> or other miRNAs might be targeted therapeutically to increase hPGRN levels in some FTD patients.
miRNA-corp.d54.s9.p0  	NA       	NA      	FALSE    	FALSE   	FALSE   	Our data indicate that overexpression of <e1>miR-21</e1> protects against ischemic neuronal death, and that downregulation of <e2>FASLG</e2>, a tumor necrosis factor-α family member and an important cell death-inducing ligand whose gene is targeted by miR-21, probably mediates the neuroprotective effect.
miRNA-corp.d54.s9.p1  	NA       	NA      	FALSE    	FALSE   	FALSE   	Our data indicate that overexpression of <e1>miR-21</e1> protects against ischemic neuronal death, and that downregulation of FASLG, a <e2>tumor necrosis factor-α </e2>family member and an important cell death-inducing ligand whose gene is targeted by miR-21, probably mediates the neuroprotective effect.
miRNA-corp.d54.s9.p2  	MIR_GENE 	TARGET      	TRUE    	FALSE   	FALSE   	Our data indicate that overexpression of miR-21 protects against ischemic neuronal death, and that downregulation of <e2>FASLG</e2>, a tumor necrosis factor-α family member and an important cell death-inducing ligand whose gene is targeted by <e1>miR-21</e1>, probably mediates the neuroprotective effect.
miRNA-corp.d54.s9.p3  	NA       	NA      	FALSE    	FALSE   	FALSE   	Our data indicate that overexpression of miR-21 protects against ischemic neuronal death, and that downregulation of FASLG, a <e2>tumor necrosis factor-α </e2>family member and an important cell death-inducing ligand whose gene is targeted by <e1>miR-21</e1>, probably mediates the neuroprotective effect.
miRNA-corp.d54.s10.p0 	NA       	NA      	FALSE    	FALSE   	FALSE   	Moreover, overexpression of <e1>miR-21</e1> in neurons significantly reduced FASLG levels, and introduction of an miR-21 mimic into 293-HEK cells substantially reduced luciferase activity in a reporter system containing the 3'-UTR of <e2>Faslg</e2>.
miRNA-corp.d54.s10.p1 	MIR_GENE 	DOWN    	FALSE    	FALSE   	FALSE   	Moreover, overexpression of <e1>miR-21</e1> in neurons significantly reduced <e2>FASLG</e2> levels, and introduction of an miR-21 mimic into 293-HEK cells substantially reduced luciferase activity in a reporter system containing the 3'-UTR of Faslg.
miRNA-corp.d54.s10.p2 	MIR_GENE 	DOWN    	FALSE    	FALSE   	FALSE   	Moreover, overexpression of miR-21 in neurons significantly reduced FASLG levels, and introduction of an <e1>miR-21</e1> mimic into 293-HEK cells substantially reduced luciferase activity in a reporter system containing the 3'-UTR of <e2>Faslg</e2>.
miRNA-corp.d54.s10.p3 	NA       	NA      	FALSE    	FALSE   	FALSE   	Moreover, overexpression of miR-21 in neurons significantly reduced <e2>FASLG</e2> levels, and introduction of an <e1>miR-21</e1> mimic into 293-HEK cells substantially reduced luciferase activity in a reporter system containing the 3'-UTR of Faslg.
miRNA-corp.d56.s2.p3  	MIR_GENE 	TARGET    	FALSE    	FALSE   	FALSE   	Three microRNA upregulated in active multiple sclerosis lesions (<e1>microRNA-34a</e1>, microRNA-155 and microRNA-326) targeted the 3'-untranslated region of <e2>CD47</e2> in reporter assays, with microRNA-155 even at two distinct sites.
miRNA-corp.d56.s2.p5  	MIR_GENE 	TARGET    	FALSE    	FALSE   	FALSE   	Three microRNA upregulated in active multiple sclerosis lesions (microRNA-34a, <e1>microRNA-155</e1> and microRNA-326) targeted the 3'-untranslated region of <e2>CD47</e2> in reporter assays, with microRNA-155 even at two distinct sites.
miRNA-corp.d56.s2.p7  	MIR_GENE 	TARGET    	FALSE    	FALSE   	FALSE   	Three microRNA upregulated in active multiple sclerosis lesions (microRNA-34a, microRNA-155 and <e1>microRNA-326</e1>) targeted the 3'-untranslated region of <e2>CD47</e2> in reporter assays, with microRNA-155 even at two distinct sites.
miRNA-corp.d56.s2.p9  	NA       	NA      	FALSE    	FALSE   	FALSE   	Three microRNA upregulated in active multiple sclerosis lesions (microRNA-34a, microRNA-155 and microRNA-326) targeted the 3'-untranslated region of <e2>CD47</e2> in reporter assays, with <e1>microRNA-155</e1> even at two distinct sites.
miRNA-corp.d57.s1.p0  	MIR_GENE 	TARGET    	FALSE    	FALSE   	FALSE   	The miRNA <e1>miR-23a</e1> was predicted to bind <e2>XIAP</e2> mRNA.
miRNA-corp.d57.s2.p0  	MIR_GENE 	TARGET    	FALSE    	FALSE   	FALSE   	<e1>miR-23a</e1> directly bound the 3' UTR of <e2>XIAP</e2>, and miR-23a inhibition led to an increase in XIAP mRNA in vitro, demonstrating that XIAP is a previously uncharacterized target for miR-23a.
miRNA-corp.d57.s2.p1  	NA       	NA      	FALSE    	FALSE   	FALSE   	<e1>miR-23a</e1> directly bound the 3' UTR of XIAP, and miR-23a inhibition led to an increase in <e2>XIAP</e2> mRNA in vitro, demonstrating that XIAP is a previously uncharacterized target for miR-23a.
miRNA-corp.d57.s2.p2  	NA       	NA      	FALSE    	FALSE   	FALSE   	<e1>miR-23a</e1> directly bound the 3' UTR of XIAP, and miR-23a inhibition led to an increase in XIAP mRNA in vitro, demonstrating that <e2>XIAP</e2> is a previously uncharacterized target for miR-23a.
miRNA-corp.d57.s2.p3  	NA       	NA      	FALSE    	FALSE   	FALSE   	miR-23a directly bound the 3' UTR of <e2>XIAP</e2>, and <e1>miR-23a</e1> inhibition led to an increase in XIAP mRNA in vitro, demonstrating that XIAP is a previously uncharacterized target for miR-23a.
miRNA-corp.d57.s2.p4  	MIR_GENE 	DOWN    	TRUE    	FALSE   	FALSE   	miR-23a directly bound the 3' UTR of XIAP, and <e1>miR-23a</e1> inhibition led to an increase in <e2>XIAP</e2> mRNA in vitro, demonstrating that XIAP is a previously uncharacterized target for miR-23a.
miRNA-corp.d57.s2.p5  	NA       	NA      	FALSE    	FALSE   	FALSE   	miR-23a directly bound the 3' UTR of XIAP, and <e1>miR-23a</e1> inhibition led to an increase in XIAP mRNA in vitro, demonstrating that <e2>XIAP</e2> is a previously uncharacterized target for miR-23a.
miRNA-corp.d57.s2.p6  	NA       	NA      	FALSE    	FALSE   	FALSE   	miR-23a directly bound the 3' UTR of <e2>XIAP</e2>, and miR-23a inhibition led to an increase in XIAP mRNA in vitro, demonstrating that XIAP is a previously uncharacterized target for <e1>miR-23a</e1>.
miRNA-corp.d57.s2.p7  	NA       	NA      	FALSE    	FALSE   	FALSE   	miR-23a directly bound the 3' UTR of XIAP, and miR-23a inhibition led to an increase in <e2>XIAP</e2> mRNA in vitro, demonstrating that XIAP is a previously uncharacterized target for <e1>miR-23a</e1>.
miRNA-corp.d57.s2.p8  	MIR_GENE 	TARGET      	FALSE    	FALSE   	FALSE   	miR-23a directly bound the 3' UTR of XIAP, and miR-23a inhibition led to an increase in XIAP mRNA in vitro, demonstrating that <e2>XIAP</e2> is a previously uncharacterized target for <e1>miR-23a</e1>.
miRNA-corp.d57.s7.p0  	MIR_GENE 	TARGET    	FALSE    	FALSE   	FALSE   	<e1>miR-23a</e1> regulation of <e2>X-linked inhibitor of apoptosis</e2> (XIAP) contributes to sex differences in the response to cerebral ischemia.
miRNA-corp.d57.s7.p1  	MIR_GENE 	TARGET    	FALSE    	FALSE   	FALSE   	<e1>miR-23a</e1> regulation of X-linked inhibitor of apoptosis (<e2>XIAP</e2>) contributes to sex differences in the response to cerebral ischemia.
miRNA-corp.d61.s2.p0  	MIR_GENE 	DOWN    	FALSE    	FALSE   	FALSE   	Transfection of <e1>let-7</e1> miRNA reduced expression of <e2>pan-RAS</e2>, N-RAS, and K-RAS in the glioblastoma cells.
miRNA-corp.d61.s2.p1  	MIR_GENE 	DOWN    	FALSE    	FALSE   	FALSE   	Transfection of <e1>let-7</e1> miRNA reduced expression of pan-RAS, <e2>N-RAS</e2>, and K-RAS in the glioblastoma cells.
miRNA-corp.d61.s2.p2  	MIR_GENE 	DOWN    	FALSE    	FALSE   	FALSE   	Transfection of <e1>let-7</e1> miRNA reduced expression of pan-RAS, N-RAS, and <e2>K-RAS</e2> in the glioblastoma cells.
miRNA-corp.d62.s2.p5  	NA       	NA      	FALSE    	FALSE   	FALSE   	Our preliminary studies unexpectedly revealed that accumulation of myocardin in response to proteasome inhibition by MG132 or lactacystin resulted in decrease of transcriptional activity of myocardin as indicated by reduced expression of SMC contractile marker genes (SM α-actin, <e2>SM22</e2>, and calponin) and muscle-enriched microRNAs (<e1>miR-143/145</e1> and miR-1/133a), and reduced contractility of human vascular smooth muscle cells (SMCs) embedded in collagen gel lattices, suggesting that myocardin degradation is required for its transcriptional activity.
miRNA-corp.d62.s2.p6  	NA       	NA      	FALSE    	FALSE   	FALSE   	Our preliminary studies unexpectedly revealed that accumulation of myocardin in response to proteasome inhibition by MG132 or lactacystin resulted in decrease of transcriptional activity of myocardin as indicated by reduced expression of SMC contractile marker genes (SM α-actin, SM22, and <e2>calponin</e2>) and muscle-enriched microRNAs (<e1>miR-143/145</e1> and miR-1/133a), and reduced contractility of human vascular smooth muscle cells (SMCs) embedded in collagen gel lattices, suggesting that myocardin degradation is required for its transcriptional activity.
miRNA-corp.d62.s2.p7  	NA       	NA      	FALSE    	FALSE   	FALSE   	Our preliminary studies unexpectedly revealed that accumulation of myocardin in response to proteasome inhibition by MG132 or lactacystin resulted in decrease of transcriptional activity of <e2>myocardin</e2> as indicated by reduced expression of SMC contractile marker genes (SM α-actin, SM22, and calponin) and muscle-enriched microRNAs (<e1>miR-143/145</e1> and miR-1/133a), and reduced contractility of human vascular smooth muscle cells (SMCs) embedded in collagen gel lattices, suggesting that myocardin degradation is required for its transcriptional activity.
miRNA-corp.d62.s2.p8  	NA       	NA      	FALSE    	FALSE   	FALSE   	Our preliminary studies unexpectedly revealed that accumulation of myocardin in response to proteasome inhibition by MG132 or lactacystin resulted in decrease of transcriptional activity of myocardin as indicated by reduced expression of SMC contractile marker genes (SM α-actin, SM22, and calponin) and muscle-enriched microRNAs (<e1>miR-143/145</e1> and miR-1/133a), and reduced contractility of human vascular smooth muscle cells (SMCs) embedded in collagen gel lattices, suggesting that <e2>myocardin</e2> degradation is required for its transcriptional activity.
miRNA-corp.d62.s2.p9  	NA       	NA      	FALSE    	FALSE   	FALSE   	Our preliminary studies unexpectedly revealed that accumulation of <e2>myocardin</e2> in response to proteasome inhibition by MG132 or lactacystin resulted in decrease of transcriptional activity of myocardin as indicated by reduced expression of SMC contractile marker genes (SM α-actin, SM22, and calponin) and muscle-enriched microRNAs (<e1>miR-143/145</e1> and miR-1/133a), and reduced contractility of human vascular smooth muscle cells (SMCs) embedded in collagen gel lattices, suggesting that myocardin degradation is required for its transcriptional activity.
miRNA-corp.d62.s2.p10 	NA       	NA      	FALSE    	FALSE   	FALSE   	Our preliminary studies unexpectedly revealed that accumulation of myocardin in response to proteasome inhibition by MG132 or lactacystin resulted in decrease of transcriptional activity of myocardin as indicated by reduced expression of SMC contractile marker genes (SM α-actin, <e2>SM22</e2>, and calponin) and muscle-enriched microRNAs (miR-143/145 and <e1>miR-1/133a</e1>), and reduced contractility of human vascular smooth muscle cells (SMCs) embedded in collagen gel lattices, suggesting that myocardin degradation is required for its transcriptional activity.
miRNA-corp.d62.s2.p11 	NA       	NA      	FALSE    	FALSE   	FALSE   	Our preliminary studies unexpectedly revealed that accumulation of myocardin in response to proteasome inhibition by MG132 or lactacystin resulted in decrease of transcriptional activity of myocardin as indicated by reduced expression of SMC contractile marker genes (SM α-actin, SM22, and <e2>calponin</e2>) and muscle-enriched microRNAs (miR-143/145 and <e1>miR-1/133a</e1>), and reduced contractility of human vascular smooth muscle cells (SMCs) embedded in collagen gel lattices, suggesting that myocardin degradation is required for its transcriptional activity.
miRNA-corp.d62.s2.p12 	NA       	NA      	FALSE    	FALSE   	FALSE   	Our preliminary studies unexpectedly revealed that accumulation of myocardin in response to proteasome inhibition by MG132 or lactacystin resulted in decrease of transcriptional activity of <e2>myocardin</e2> as indicated by reduced expression of SMC contractile marker genes (SM α-actin, SM22, and calponin) and muscle-enriched microRNAs (miR-143/145 and <e1>miR-1/133a</e1>), and reduced contractility of human vascular smooth muscle cells (SMCs) embedded in collagen gel lattices, suggesting that myocardin degradation is required for its transcriptional activity.
miRNA-corp.d62.s2.p13 	NA       	NA      	FALSE    	FALSE   	FALSE   	Our preliminary studies unexpectedly revealed that accumulation of myocardin in response to proteasome inhibition by MG132 or lactacystin resulted in decrease of transcriptional activity of myocardin as indicated by reduced expression of SMC contractile marker genes (SM α-actin, SM22, and calponin) and muscle-enriched microRNAs (miR-143/145 and <e1>miR-1/133a</e1>), and reduced contractility of human vascular smooth muscle cells (SMCs) embedded in collagen gel lattices, suggesting that <e2>myocardin</e2> degradation is required for its transcriptional activity.
miRNA-corp.d62.s2.p14 	NA       	NA      	FALSE    	FALSE   	FALSE   	Our preliminary studies unexpectedly revealed that accumulation of <e2>myocardin</e2> in response to proteasome inhibition by MG132 or lactacystin resulted in decrease of transcriptional activity of myocardin as indicated by reduced expression of SMC contractile marker genes (SM α-actin, SM22, and calponin) and muscle-enriched microRNAs (miR-143/145 and <e1>miR-1/133a</e1>), and reduced contractility of human vascular smooth muscle cells (SMCs) embedded in collagen gel lattices, suggesting that myocardin degradation is required for its transcriptional activity.
miRNA-corp.d63.s1.p0  	MIR_GENE 	DOWN    	TRUE    	FALSE   	FALSE   	Overexpression of <e1>mir-7</e1> and mir-153 significantly reduces endogenous <e2>alpha-synuclein</e2> levels, whereas inhibition of mir-7 and mir-153 enhances translation of a luciferase construct bearing the alpha-synuclein 3'-untranslated region in primary neurons.
miRNA-corp.d63.s1.p1  	NA       	NA      	FALSE    	FALSE   	FALSE   	Overexpression of <e1>mir-7</e1> and mir-153 significantly reduces endogenous alpha-synuclein levels, whereas inhibition of mir-7 and mir-153 enhances translation of a luciferase construct bearing the <e2>alpha-synuclein</e2> 3'-untranslated region in primary neurons.
miRNA-corp.d63.s1.p2  	MIR_GENE 	DOWN    	TRUE    	FALSE   	FALSE   	Overexpression of mir-7 and <e1>mir-153</e1> significantly reduces endogenous <e2>alpha-synuclein</e2> levels, whereas inhibition of mir-7 and mir-153 enhances translation of a luciferase construct bearing the alpha-synuclein 3'-untranslated region in primary neurons.
miRNA-corp.d63.s1.p3  	NA       	NA      	FALSE    	FALSE   	FALSE   	Overexpression of mir-7 and <e1>mir-153</e1> significantly reduces endogenous alpha-synuclein levels, whereas inhibition of mir-7 and mir-153 enhances translation of a luciferase construct bearing the <e2>alpha-synuclein</e2> 3'-untranslated region in primary neurons.
miRNA-corp.d63.s1.p4  	NA       	NA      	FALSE    	FALSE   	FALSE   	Overexpression of mir-7 and mir-153 significantly reduces endogenous <e2>alpha-synuclein</e2> levels, whereas inhibition of <e1>mir-7</e1> and mir-153 enhances translation of a luciferase construct bearing the alpha-synuclein 3'-untranslated region in primary neurons.
miRNA-corp.d63.s1.p5  	MIR_GENE 	DOWN    	TRUE    	FALSE   	FALSE   	Overexpression of mir-7 and mir-153 significantly reduces endogenous alpha-synuclein levels, whereas inhibition of <e1>mir-7</e1> and mir-153 enhances translation of a luciferase construct bearing the <e2>alpha-synuclein</e2> 3'-untranslated region in primary neurons.
miRNA-corp.d63.s1.p6  	NA       	NA      	FALSE    	FALSE   	FALSE   	Overexpression of mir-7 and mir-153 significantly reduces endogenous <e2>alpha-synuclein</e2> levels, whereas inhibition of mir-7 and <e1>mir-153</e1> enhances translation of a luciferase construct bearing the alpha-synuclein 3'-untranslated region in primary neurons.
miRNA-corp.d63.s1.p7  	MIR_GENE 	DOWN    	TRUE    	FALSE   	FALSE   	Overexpression of mir-7 and mir-153 significantly reduces endogenous alpha-synuclein levels, whereas inhibition of mir-7 and <e1>mir-153</e1> enhances translation of a luciferase construct bearing the <e2>alpha-synuclein</e2> 3'-untranslated region in primary neurons.
miRNA-corp.d63.s4.p1  	MIR_GENE 	TARGET    	FALSE    	FALSE   	FALSE   	Here, two microRNAs, namely <e1>mir-7</e1> and mir-153, have been identified to regulate <e2>alpha-synuclein</e2> levels post-transcriptionally.
miRNA-corp.d63.s4.p2  	MIR_GENE 	TARGET    	FALSE    	FALSE   	FALSE   	Here, two microRNAs, namely mir-7 and <e1>mir-153</e1>, have been identified to regulate <e2>alpha-synuclein</e2> levels post-transcriptionally.
miRNA-corp.d63.s6.p0  	MIR_GENE 	TARGET      	TRUE    	FALSE   	FALSE   	Post-transcriptional regulation of <e2>alpha-synuclein</e2> expression by <e1>mir-7</e1> and mir-153.
miRNA-corp.d63.s6.p1  	MIR_GENE 	TARGET      	TRUE    	FALSE   	FALSE   	Post-transcriptional regulation of <e2>alpha-synuclein</e2> expression by mir-7 and <e1>mir-153</e1>.
miRNA-corp.d66.s2.p0  	MIR_GENE 	TARGET      	TRUE    	FALSE   	FALSE   	We found that the A allele of rs2507800 suppressed <e2>angiopoietin-1</e2> translation by facilitating <e1>miR-211</e1> binding, but not the T allele.
miRNA-corp.d66.s4.p0  	MIR_GENE 	TARGET    	FALSE    	FALSE   	FALSE   	To test our hypothesis, a predicted microRNA-binding site was found in the 3'-UTR of angiopoietin-1 using bioinformatics; variant rs2507800 was identified to be located in the <e1>miR-211</e1>-binding site of <e2>angiopoietin-1</e2>.
miRNA-corp.d66.s4.p1  	NA       	NA      	FALSE    	FALSE   	FALSE   	To test our hypothesis, a predicted microRNA-binding site was found in the 3'-UTR of <e2>angiopoietin-1</e2> using bioinformatics; variant rs2507800 was identified to be located in the <e1>miR-211</e1>-binding site of angiopoietin-1.
miRNA-corp.d66.s8.p0  	MIR_GENE 	TARGET      	FALSE    	FALSE   	FALSE   	A functional variant in the 3'-UTR of <e2>angiopoietin-1</e2> might reduce stroke risk by interfering with the binding efficiency of <e1>microRNA 211</e1>.
miRNA-corp.d66.s9.p1  	MIR_GENE 	NEU      	TRUE    	FALSE   	FALSE   	Our results provide evidence that the TT genotype (rs2507800) in the 3'-UTR of <e2>angiopoietin-1</e2> might reduce the risk of stroke by interfering with <e1>miR-211</e1> binding.
miRNA-corp.d69.s0.p0  	MIR_GENE 	NEU    	FALSE    	FALSE   	FALSE   	These findings indicate that <e1>miR-107</e1> contributes to <e2>GRN</e2> expression regulation with implications for brain disorders.
miRNA-corp.d69.s1.p0  	NA       	NA      	FALSE    	FALSE   	FALSE   	In brain tissue subjacent to 1.0 mm depth controlled cortical impact, surviving hippocampal neurons show decreased <e1>miR-107</e1> with augmentation of neuronal <e2>GRN</e2> expression.
miRNA-corp.d69.s4.p2  	MIR_GENE 	TARGET      	FALSE    	FALSE   	FALSE   	A high-throughput experimental microRNA assay showed that <e2>GRN</e2> is the strongest target for <e1>miR-107</e1> in human H4 neuroglioma cells.
miRNA-corp.d69.s5.p1  	NA       	NA      	FALSE    	FALSE   	FALSE   	<e1>miR-107</e1> has been implicated in Alzheimer's disease pathogenesis, and sequence elements in the open reading frame-rather than the 3' untranslated region-of <e2>GRN</e2> mRNA are recognized by miR-107 and are highly conserved among vertebrate species.
miRNA-corp.d69.s5.p3  	MIR_GENE 	TARGET      	TRUE    	FALSE   	FALSE   	miR-107 has been implicated in Alzheimer's disease pathogenesis, and sequence elements in the open reading frame-rather than the 3' untranslated region-of <e2>GRN</e2> mRNA are recognized by <e1>miR-107</e1> and are highly conserved among vertebrate species.
miRNA-corp.d69.s7.p0  	MIR_GENE 	NEU    	FALSE    	FALSE   	FALSE   	<e1>miR-107</e1> regulates <e2>granulin</e2>/progranulin with implications for traumatic brain injury and neurodegenerative disease.
miRNA-corp.d69.s7.p1  	MIR_GENE 	NEU    	FALSE    	FALSE   	FALSE   	<e1>miR-107</e1> regulates granulin/<e2>progranulin</e2> with implications for traumatic brain injury and neurodegenerative disease.
miRNA-corp.d69.s10.p0 	NA       	NA      	FALSE    	FALSE   	FALSE   	GRN mRNA interacts preferentially with <e2>Argonaute 2</e2>. In vitro and in vivo studies indicate that regulation of GRN by <e1>miR-107</e1> may be functionally important.
miRNA-corp.d69.s10.p1 	NA       	NA      	FALSE    	FALSE   	FALSE   	<e2>GRN</e2> mRNA interacts preferentially with Argonaute 2. In vitro and in vivo studies indicate that regulation of GRN by <e1>miR-107</e1> may be functionally important.
miRNA-corp.d69.s10.p2 	MIR_GENE 	NEU      	TRUE    	FALSE   	FALSE   	GRN mRNA interacts preferentially with Argonaute 2. In vitro and in vivo studies indicate that regulation of <e2>GRN</e2> by <e1>miR-107</e1> may be functionally important.
miRNA-corp.d69.s11.p0 	MIR_GENE 	DOWN    	TRUE    	FALSE   	FALSE   	Glucose supplementation in cultured cells that leads to increased <e1>miR-107</e1> levels also results in decreased <e2>GRN</e2> expression, including changes in cell compartmentation and decreased secretion of GRN protein.
miRNA-corp.d69.s11.p1 	MIR_GENE 	DOWN    	TRUE    	FALSE   	FALSE   	Glucose supplementation in cultured cells that leads to increased <e1>miR-107</e1> levels also results in decreased GRN expression, including changes in cell compartmentation and decreased secretion of <e2>GRN</e2> protein.
miRNA-corp.d70.s1.p0  	MIR_GENE 	DOWN    	FALSE    	FALSE   	FALSE   	<e1>MiR-21</e1> protected human glioblastoma U87MG cells from chemotherapeutic drug temozolomide induced apoptosis by decreasing Bax/Bcl-2 ratio and <e2>caspase-3</e2> activity.
miRNA-corp.d70.s1.p2  	MIR_GENE 	DOWN    	FALSE    	FALSE   	FALSE   	<e1>MiR-21</e1> protected human glioblastoma U87MG cells from chemotherapeutic drug temozolomide induced apoptosis by decreasing <e2>Bax</e2>/Bcl-2 ratio and caspase-3 activity.
miRNA-corp.d70.s1.p3  	MIR_GENE 	DOWN    	FALSE    	FALSE   	FALSE   	<e1>MiR-21</e1> protected human glioblastoma U87MG cells from chemotherapeutic drug temozolomide induced apoptosis by decreasing Bax/<e2>Bcl-2</e2> ratio and caspase-3 activity.
miRNA-corp.d70.s12.p0 	MIR_GENE 	DOWN    	FALSE    	FALSE   	FALSE   	However, such effect was partly prevented by treatment of cells with <e1>miR-21</e1> overexpression before, which appeared to downregulate the <e2>Bax</e2> expression, upregulate the Bcl-2 expression and decrease caspase-3 activity.
miRNA-corp.d70.s12.p1 	MIR_GENE       	UP      	TRUE    	FALSE   	FALSE   	However, such effect was partly prevented by treatment of cells with <e1>miR-21</e1> overexpression before, which appeared to downregulate the Bax expression, upregulate the <e2>Bcl-2</e2> expression and decrease caspase-3 activity.
miRNA-corp.d70.s12.p2 	MIR_GENE       	DOWN      	FALSE    	FALSE   	FALSE   	However, such effect was partly prevented by treatment of cells with <e1>miR-21</e1> overexpression before, which appeared to downregulate the Bax expression, upregulate the Bcl-2 expression and decrease <e2>caspase-3</e2> activity.
miRNA-corp.d70.s14.p0 	NA       	NA      	FALSE    	FALSE   	FALSE   	Taken together, these results suggested that over-express <e1>miR-21</e1> could inhibit TMZ-induced apoptosis in U87MG cells, at least in part, by decreasing <e2>Bax</e2>/Bcl-2 ratio and caspase-3 activity, which highlighted the possibility of miR-21 overexpression in the clinical resistance to chemotherapeutic therapy of TMZ.
miRNA-corp.d70.s14.p1 	NA       	NA      	FALSE    	FALSE   	FALSE   	Taken together, these results suggested that over-express <e1>miR-21</e1> could inhibit TMZ-induced apoptosis in U87MG cells, at least in part, by decreasing Bax/<e2>Bcl-2</e2> ratio and caspase-3 activity, which highlighted the possibility of miR-21 overexpression in the clinical resistance to chemotherapeutic therapy of TMZ.
miRNA-corp.d70.s14.p2 	NA       	NA      	FALSE    	FALSE   	FALSE   	Taken together, these results suggested that over-express <e1>miR-21</e1> could inhibit TMZ-induced apoptosis in U87MG cells, at least in part, by decreasing Bax/Bcl-2 ratio and <e2>caspase-3</e2> activity, which highlighted the possibility of miR-21 overexpression in the clinical resistance to chemotherapeutic therapy of TMZ.
miRNA-corp.d70.s14.p3 	NA       	NA      	FALSE    	FALSE   	FALSE   	Taken together, these results suggested that over-express miR-21 could inhibit TMZ-induced apoptosis in U87MG cells, at least in part, by decreasing <e2>Bax</e2>/Bcl-2 ratio and caspase-3 activity, which highlighted the possibility of <e1>miR-21</e1> overexpression in the clinical resistance to chemotherapeutic therapy of TMZ.
miRNA-corp.d70.s14.p4 	NA       	NA      	FALSE    	FALSE   	FALSE   	Taken together, these results suggested that over-express miR-21 could inhibit TMZ-induced apoptosis in U87MG cells, at least in part, by decreasing Bax/<e2>Bcl-2</e2> ratio and caspase-3 activity, which highlighted the possibility of <e1>miR-21</e1> overexpression in the clinical resistance to chemotherapeutic therapy of TMZ.
miRNA-corp.d70.s14.p5 	NA       	NA      	FALSE    	FALSE   	FALSE   	Taken together, these results suggested that over-express miR-21 could inhibit TMZ-induced apoptosis in U87MG cells, at least in part, by decreasing Bax/Bcl-2 ratio and <e2>caspase-3</e2> activity, which highlighted the possibility of <e1>miR-21</e1> overexpression in the clinical resistance to chemotherapeutic therapy of TMZ.
miRNA-corp.d71.s0.p1  	MIR_GENE 	NEU      	TRUE    	TRUE   	FALSE   	Hypoxia induces microRNA miR-210 in vitro and in vivo <e2>ephrin-A3</e2> and neuronal pentraxin 1 are potentially regulated by <e1>miR-210</e1>.
miRNA-corp.d71.s0.p2  	MIR_GENE 	NEU      	TRUE    	TRUE   	FALSE   	Hypoxia induces microRNA miR-210 in vitro and in vivo ephrin-A3 and <e2>neuronal pentraxin 1</e2> are potentially regulated by <e1>miR-210</e1>.
miRNA-corp.d71.s0.p4  	NA       	NA      	FALSE    	FALSE   	FALSE   	Hypoxia induces microRNA <e1>miR-210</e1> in vitro and in vivo <e2>ephrin-A3</e2> and neuronal pentraxin 1 are potentially regulated by miR-210.
miRNA-corp.d71.s0.p5  	NA       	NA      	FALSE    	FALSE   	FALSE   	Hypoxia induces microRNA <e1>miR-210</e1> in vitro and in vivo ephrin-A3 and <e2>neuronal pentraxin 1</e2> are potentially regulated by miR-210.
miRNA-corp.d71.s3.p0  	GENE_MIR 	UP      	FALSE    	FALSE   	FALSE   	An active form of the <e2>HIF-1alpha</e2> induced the expression of <e1>miR-210</e1>, showing the involvement of the HIF-1 signaling pathway in miR-210 gene transcription.
miRNA-corp.d71.s3.p1  	NA       	NA      	FALSE    	FALSE   	FALSE   	An active form of the HIF-1alpha induced the expression of <e1>miR-210</e1>, showing the involvement of the <e2>HIF-1</e2> signaling pathway in miR-210 gene transcription.
miRNA-corp.d71.s3.p2  	NA       	NA      	FALSE    	FALSE   	FALSE   	An active form of the <e2>HIF-1alpha</e2> induced the expression of miR-210, showing the involvement of the HIF-1 signaling pathway in <e1>miR-210</e1> gene transcription.
miRNA-corp.d71.s3.p3  	NA       	NA      	FALSE    	FALSE   	FALSE   	An active form of the HIF-1alpha induced the expression of miR-210, showing the involvement of the <e2>HIF-1</e2> signaling pathway in <e1>miR-210</e1> gene transcription.
miRNA-corp.d71.s4.p0  	MIR_GENE 	TARGET    	FALSE    	FALSE   	FALSE   	Furthermore, <e1>miR-210</e1> was shown to bind to the predicted target sites of <e2>ephrin-A3</e2> or neuronal pentraxin 1, causing repression in luciferase reporter activity.
miRNA-corp.d71.s4.p1  	MIR_GENE 	TARGET    	FALSE    	FALSE   	FALSE   	Furthermore, <e1>miR-210</e1> was shown to bind to the predicted target sites of ephrin-A3 or <e2>neuronal pentraxin 1</e2>, causing repression in luciferase reporter activity.
miRNA-corp.d74.s7.p0  	MIR_GENE 	DOWN    	FALSE    	FALSE   	FALSE   	When overexpressed in macrophages, <e1>miR-124</e1> directly inhibited the transcription factor CCAAT/<e2>enhancer-binding protein-α</e2> (C/EBP-α) and its downstream target PU.1, resulting in transformation of these cells from an activated phenotype into a quiescent CD45(low), major histocompatibility complex (MHC) class II(low) phenotype resembling resting microglia.
miRNA-corp.d74.s7.p1  	MIR_GENE 	DOWN    	FALSE    	FALSE   	FALSE   	When overexpressed in macrophages, <e1>miR-124</e1> directly inhibited the transcription factor CCAAT/enhancer-binding protein-α (<e2>C/EBP-α</e2>) and its downstream target PU.1, resulting in transformation of these cells from an activated phenotype into a quiescent CD45(low), major histocompatibility complex (MHC) class II(low) phenotype resembling resting microglia.
miRNA-corp.d74.s7.p2  	NA       	NA      	FALSE    	FALSE   	FALSE   	When overexpressed in macrophages, <e1>miR-124</e1> directly inhibited the transcription factor CCAAT/enhancer-binding protein-α (C/EBP-α) and its downstream target <e2>PU.1</e2>, resulting in transformation of these cells from an activated phenotype into a quiescent CD45(low), major histocompatibility complex (MHC) class II(low) phenotype resembling resting microglia.
miRNA-corp.d76.s4.p0  	NA       	NA      	FALSE    	FALSE   	FALSE   	<e1>MiR-451</e1> levels are regulated by glucose; under conditions of abundant energy miR-451 expression is high, and the suppression of AMPK signaling allows cells to maintain elevated proliferation rates via unrestrained <e2>mTOR</e2> activation.
miRNA-corp.d76.s4.p1  	NA       	NA      	FALSE    	FALSE   	FALSE   	MiR-451 levels are regulated by glucose; under conditions of abundant energy <e1>miR-451</e1> expression is high, and the suppression of AMPK signaling allows cells to maintain elevated proliferation rates via unrestrained <e2>mTOR</e2> activation.
miRNA-corp.d77.s4.p0  	NA       	NA      	FALSE    	FALSE   	FALSE   	<e1>miR-206</e1> mediates these effects at least in part through <e2>histone deacetylase 4</e2> and fibroblast growth factor signaling pathways.
miRNA-corp.d80.s1.p0  	MIR_GENE 	NEU      	FALSE    	TRUE   	FALSE   	Our data strongly indicate that <e2>CDK6</e2> is regulated by <e1>microRNA 124</e1> in medulloblastoma and that miR 124 modulates medulloblastoma cell growth.
miRNA-corp.d80.s1.p3  	NA       	NA      	FALSE    	FALSE   	FALSE   	Our data strongly indicate that <e2>CDK6</e2> is regulated by microRNA 124 in medulloblastoma and that <e1>miR-124</e1> modulates medulloblastoma cell growth.
miRNA-corp.d80.s5.p1  	MIR_GENE 	TARGET      	FALSE    	FALSE   	FALSE   	We identified putative miR sites in the <e2>CDK6</e2> including <e1>microRNA 124a</e1>, a brain enriched microRNA.
miRNA-corp.d80.s6.p1  	MIR_GENE 	DOWN    	FALSE    	FALSE   	FALSE   	Additionally, re-expression of <e1>miR-124a</e1> in medulloblastoma cells decreased expression of <e2>CDK6</e2> protein.
miRNA-corp.d80.s7.p0  	MIR_GENE 	TARGET    	FALSE    	FALSE   	FALSE   	Functional association between <e1>miR-124a</e1> and <e2>CDK6</e2> in medulloblastoma was established using luciferase assays.
miRNA-corp.d80.s9.p1  	MIR_GENE 	DOWN      	TRUE    	FALSE   	FALSE   	Regulation of <e2>cyclin dependent kinase 6</e2> by <e1>microRNA 124</e1> in medulloblastoma.
miRNA-corp.d84.s0.p0  	MIR_GENE 	TARGET    	FALSE    	FALSE   	FALSE   	These cellular responses are mediated by augmented expression of the direct targets of <e1>miR-10b</e1>, including <e2>BCL2L11</e2>/Bim, TFAP2C/AP-2γ, CDKN1A/p21, and CDKN2A/p16, which normally protect cells from uncontrolled growth.
miRNA-corp.d84.s0.p1  	MIR_GENE 	TARGET    	FALSE    	FALSE   	FALSE   	These cellular responses are mediated by augmented expression of the direct targets of <e1>miR-10b</e1>, including BCL2L11/<e2>Bim</e2>, TFAP2C/AP-2γ, CDKN1A/p21, and CDKN2A/p16, which normally protect cells from uncontrolled growth.
miRNA-corp.d84.s0.p2  	MIR_GENE 	TARGET    	FALSE    	FALSE   	FALSE   	These cellular responses are mediated by augmented expression of the direct targets of <e1>miR-10b</e1>, including BCL2L11/Bim, <e2>TFAP2C</e2>/AP-2γ, CDKN1A/p21, and CDKN2A/p16, which normally protect cells from uncontrolled growth.
miRNA-corp.d84.s0.p3  	MIR_GENE 	TARGET    	FALSE    	FALSE   	FALSE   	These cellular responses are mediated by augmented expression of the direct targets of <e1>miR-10b</e1>, including BCL2L11/Bim, TFAP2C/<e2>AP-2γ</e2>, CDKN1A/p21, and CDKN2A/p16, which normally protect cells from uncontrolled growth.
miRNA-corp.d84.s0.p4  	MIR_GENE 	TARGET    	FALSE    	FALSE   	FALSE   	These cellular responses are mediated by augmented expression of the direct targets of <e1>miR-10b</e1>, including BCL2L11/Bim, TFAP2C/AP-2γ, <e2>CDKN1A</e2>/p21, and CDKN2A/p16, which normally protect cells from uncontrolled growth.
miRNA-corp.d84.s0.p5  	MIR_GENE 	TARGET    	FALSE    	FALSE   	FALSE   	These cellular responses are mediated by augmented expression of the direct targets of <e1>miR-10b</e1>, including BCL2L11/Bim, TFAP2C/AP-2γ, CDKN1A/<e2>p21</e2>, and CDKN2A/p16, which normally protect cells from uncontrolled growth.
miRNA-corp.d84.s0.p6  	MIR_GENE 	TARGET    	FALSE    	FALSE   	FALSE   	These cellular responses are mediated by augmented expression of the direct targets of <e1>miR-10b</e1>, including BCL2L11/Bim, TFAP2C/AP-2γ, CDKN1A/p21, and <e2>CDKN2A</e2>/p16, which normally protect cells from uncontrolled growth.
miRNA-corp.d84.s0.p7  	MIR_GENE 	TARGET    	FALSE    	FALSE   	FALSE   	These cellular responses are mediated by augmented expression of the direct targets of <e1>miR-10b</e1>, including BCL2L11/Bim, TFAP2C/AP-2γ, CDKN1A/p21, and CDKN2A/<e2>p16</e2>, which normally protect cells from uncontrolled growth.
miRNA-corp.d87.s9.p2  	MIR_GENE 	TARGET    	FALSE    	FALSE   	FALSE   	BAG2 levels in cells are under the physiological control of the microRNA <e1>miR-128a</e1>, which can tune paired helical filament <e2>Tau</e2> levels in neurons.
miRNA-corp.d87.s9.p3  	MIR_GENE 	TARGET      	FALSE    	FALSE   	FALSE   	<e2>BAG2</e2> levels in cells are under the physiological control of the microRNA <e1>miR-128a</e1>, which can tune paired helical filament Tau levels in neurons.
miRNA-corp.d88.s8.p2  	MIR_GENE 	DOWN    	FALSE    	TRUE   	FALSE   	An inverse correlation has been shown in B cell chronic lymphocytic leukemia (B-CLL) between <e1>miR-15a</e1> and miR-16-1 expression and the expression levels of <e2>arginyl-tRNA synthetase</e2> (RARS), an enzyme which associates with the cofactor p43 in the aminoacyl-tRNA synthetase complex.
miRNA-corp.d88.s8.p3  	MIR_GENE 	DOWN    	FALSE    	TRUE   	FALSE   	An inverse correlation has been shown in B cell chronic lymphocytic leukemia (B-CLL) between <e1>miR-15a</e1> and miR-16-1 expression and the expression levels of arginyl-tRNA synthetase (<e2>RARS</e2>), an enzyme which associates with the cofactor p43 in the aminoacyl-tRNA synthetase complex.
miRNA-corp.d88.s8.p6  	MIR_GENE 	DOWN    	FALSE    	TRUE   	FALSE   	An inverse correlation has been shown in B cell chronic lymphocytic leukemia (B-CLL) between miR-15a and <e1>miR-16-1</e1> expression and the expression levels of <e2>arginyl-tRNA synthetase</e2> (RARS), an enzyme which associates with the cofactor p43 in the aminoacyl-tRNA synthetase complex.
miRNA-corp.d88.s8.p7  	MIR_GENE 	DOWN    	FALSE    	TRUE   	FALSE   	An inverse correlation has been shown in B cell chronic lymphocytic leukemia (B-CLL) between miR-15a and <e1>miR-16-1</e1> expression and the expression levels of arginyl-tRNA synthetase (<e2>RARS</e2>), an enzyme which associates with the cofactor p43 in the aminoacyl-tRNA synthetase complex.
miRNA-corp.d95.s3.p0  	NA       	NA      	FALSE    	FALSE   	FALSE   	Amplification and overexpression of <e1>Hsa-miR-30b</e1>, Hsa-miR-30d and <e2>KHDRBS3</e2> at 8q24.22-q24.23 in medulloblastoma.
miRNA-corp.d95.s3.p2  	NA       	NA      	FALSE    	FALSE   	FALSE   	Amplification and overexpression of Hsa-miR-30b, <e1>Hsa-miR-30d</e1> and <e2>KHDRBS3</e2> at 8q24.22-q24.23 in medulloblastoma.
miRNA-corp.d95.s6.p0  	NA       	NA      	FALSE    	FALSE   	FALSE   	Of these, only expression of <e1>hsa-miR-30b</e1>, hsa-miR-30d and <e2>KHDRBS3</e2> correlated with copy number status, and all three of these transcripts also displayed evidence of elevated expression in sub-sets of primary medulloblastomas, measured relative to the normal cerebellum.
miRNA-corp.d95.s6.p2  	NA       	NA      	FALSE    	FALSE   	FALSE   	Of these, only expression of hsa-miR-30b, <e1>hsa-miR-30d</e1> and <e2>KHDRBS3</e2> correlated with copy number status, and all three of these transcripts also displayed evidence of elevated expression in sub-sets of primary medulloblastomas, measured relative to the normal cerebellum.
miRNA-corp.d95.s8.p2  	NA       	NA      	FALSE    	FALSE   	FALSE   	Detailed mapping identified a 3Mb common minimal region of amplification harbouring 3 coding genes (<e2>ZFAT1</e2>, LOC286094, KHDRBS3) and two genes encoding micro-RNAs (<e1>hsa-miR-30b</e1>, hsa-miR-30d).
miRNA-corp.d95.s8.p3  	NA       	NA      	FALSE    	FALSE   	FALSE   	Detailed mapping identified a 3Mb common minimal region of amplification harbouring 3 coding genes (ZFAT1, LOC286094, <e2>KHDRBS3</e2>) and two genes encoding micro-RNAs (<e1>hsa-miR-30b</e1>, hsa-miR-30d).
miRNA-corp.d95.s8.p4  	NA       	NA      	FALSE    	FALSE   	FALSE   	Detailed mapping identified a 3Mb common minimal region of amplification harbouring 3 coding genes (<e2>ZFAT1</e2>, LOC286094, KHDRBS3) and two genes encoding micro-RNAs (hsa-miR-30b, <e1>hsa-miR-30d</e1>).
miRNA-corp.d95.s8.p5  	NA       	NA      	FALSE    	FALSE   	FALSE   	Detailed mapping identified a 3Mb common minimal region of amplification harbouring 3 coding genes (ZFAT1, LOC286094, <e2>KHDRBS3</e2>) and two genes encoding micro-RNAs (hsa-miR-30b, <e1>hsa-miR-30d</e1>).
miRNA-corp.d95.s10.p0 	NA       	NA      	FALSE    	FALSE   	FALSE   	CONCLUSIONS/SIGNIFICANCE; These data implicate <e1>hsa-miR-30b</e1>, hsa-miR-30d and <e2>KHDRBS3</e2> as putative oncogenic target(s) of a novel recurrent medulloblastoma amplicon at 8q24.22-q24.23.
miRNA-corp.d95.s10.p2 	NA       	NA      	FALSE    	FALSE   	FALSE   	CONCLUSIONS/SIGNIFICANCE; These data implicate hsa-miR-30b, <e1>hsa-miR-30d</e1> and <e2>KHDRBS3</e2> as putative oncogenic target(s) of a novel recurrent medulloblastoma amplicon at 8q24.22-q24.23.
miRNA-corp.d96.s2.p1  	MIR_GENE 	REGULATE    	FALSE    	FALSE   	FALSE   	<e1>miR-29b</e1> and miR-125a regulate <e2>podoplanin</e2> and suppress invasion in glioblastoma.
miRNA-corp.d96.s2.p3  	MIR_GENE 	REGULATE    	FALSE    	FALSE   	FALSE   	miR-29b and <e1>miR-125a</e1> regulate <e2>podoplanin</e2> and suppress invasion in glioblastoma.
miRNA-corp.d96.s4.p0  	MIR_GENE 	REGULATE    	FALSE    	FALSE   	FALSE   	In this study, we focused on <e1>miR-29b</e1> and miR-125a, which were predicted to regulate <e2>PDPN</e2>, and demonstrated that these microRNAs directly target the 3' untranslated region of PDPN and inhibit invasion, apoptosis, and proliferation of glioblastomas.
miRNA-corp.d96.s4.p1  	NA       	NA      	FALSE    	FALSE   	FALSE   	In this study, we focused on <e1>miR-29b</e1> and miR-125a, which were predicted to regulate PDPN, and demonstrated that these microRNAs directly target the 3' untranslated region of <e2>PDPN</e2> and inhibit invasion, apoptosis, and proliferation of glioblastomas.
miRNA-corp.d96.s4.p3  	MIR_GENE 	REGULATE    	FALSE    	FALSE   	FALSE   	In this study, we focused on miR-29b and <e1>miR-125a</e1>, which were predicted to regulate <e2>PDPN</e2>, and demonstrated that these microRNAs directly target the 3' untranslated region of PDPN and inhibit invasion, apoptosis, and proliferation of glioblastomas.
miRNA-corp.d96.s4.p4  	NA       	NA      	FALSE    	FALSE   	FALSE   	In this study, we focused on miR-29b and <e1>miR-125a</e1>, which were predicted to regulate PDPN, and demonstrated that these microRNAs directly target the 3' untranslated region of <e2>PDPN</e2> and inhibit invasion, apoptosis, and proliferation of glioblastomas.
miRNA-corp.d97.s0.p0  	MIR_GENE 	TARGET    	FALSE    	FALSE   	FALSE   	We also found that <e1>miR-326</e1> promoted T(H)-17 differentiation by targeting <e2>Ets-1</e2>, a negative regulator of T(H)-17 differentiation.
miRNA-corp.d98.s1.p0  	MIR_GENE 	TARGET    	FALSE    	FALSE   	FALSE   	Variation in the <e1>miRNA-433</e1> binding site of <e2>FGF20</e2> confers risk for Parkinson disease by overexpression of alpha-synuclein.
miRNA-corp.d98.s1.p2  	MIR_GENE 	NEU    	FALSE    	FALSE   	FALSE   	Variation in the <e1>miRNA-433</e1> binding site of FGF20 confers risk for Parkinson disease by overexpression of <e2>alpha-synuclein</e2>.
miRNA-corp.d98.s7.p0  	NA       	NA      	FALSE    	FALSE   	FALSE   	We show in several functional assays that the risk allele for rs12720208 disrupts a binding site for <e1>microRNA-433</e1>, increasing translation of <e2>FGF20</e2> in vitro and in vivo.